The US Food and Drug Administration (FDA) has initiated an investigation into certain Indian spice products following reports of contamination with a cancer-causing pesticide. The probe was launched after Hong Kong authorities suspended the sale of three spice mixes from MDH and one from Everest, citing high levels of ethylene oxide, a substance considered carcinogenic.
The FDA’s inquiry comes in the wake of concerns raised by the international community. Singapore has also recalled an Everest spice mix used for fish curries, pointing to the same health risks associated with long-term exposure to ethylene oxide. Both MDH and Everest are renowned spice brands not only in India but across the globe, and the allegations have prompted a thorough examination of their products.
India’s Spices Board, the government body responsible for regulating spice exports, has stated that it is actively seeking detailed information on the exports of both companies to Hong Kong and Singapore. The board is also collaborating with the manufacturers to identify the root cause of the quality issues as inspections at their production facilities are underway.
Ethylene oxide is commonly used in the industry for various purposes, including as a fumigating agent for spices. However, the US Environmental Protection Agency has classified the chemical as carcinogenic to humans, linking exposure to an increased risk of lymphoid cancer and breast cancer in females.
The situation has raised alarms about food safety standards and the need for stringent quality checks on exported food products. The ongoing investigations by the US and other countries’ health authorities underscore the importance of ensuring that food products meet international safety standards to protect consumer health.
